Swiss life sciences companies must prepare for EU Data, Cybersecurity, and AI regulations, particularly the Data Act, NIS2 Directive, and AI Act. Key points include ensuring user data access, implementing cybersecurity measures, registering for NIS2 by April 2025, and compliance with high-risk AI system regulations. Although these laws are EU directives, they affect Swiss companies operating within the EU. Compliance is critical to avoid fines and maintain market access and customer trust.
